Lookup NU author(s): Dr Richard Gilbertson,
Professor Andrew Pearson,
Emeritus Professor Robert Perry,
Dr Evelyn Jaros
Full text for this publication is not currently held within this repository. Alternative links are provided below where available.
The expression and prognostic significance of the c-erbB-2 oncogene product was studied in 55 cases of childhood medulloblastoma. Forty-six of the 55 tumours (83.6%) expressed the c-erbB-2 product. The percentage of tumour cells expressing the c-erbB-2 product proved to be a significant indicator of patient outcome when analysed as both a categorical and a continuous variable. As a categorical variable, patients with more than 50% positive tumour cells had a significantly worse survival, with only 10% alive at 10 years vs 48% for those with less than 50% positive tumour cells (log rank P = 0.0049). To demonstrate that this observed prognostic significance was both independent and not a result of 'data-driven' categorisation, it was also entered into the Cox model as a continuous variable. Prognostic significance was retained with P = 0.038.
Author(s): Gilbertson RJ, Pearson ADJ, Perry RH, Jaros EAB, Kelly PJ
Publication type: Article
Publication status: Published
Journal: British Journal of Cancer
Print publication date: 01/03/1995
ISSN (print): 0007-0920
ISSN (electronic): 1532-1827
PubMed id: 7880726